ANAB – anaptysbio, inc. (US:NASDAQ)
Stock Stats
News
11/16
08:48 am
anab
Medium
Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher [Yahoo! Finance]
11/14
06:29 pm
anab
Medium
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.
11/12
10:45 am
anab
Low
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $75.00 to $66.00. They now have an "overweight" rating on the stock.
11/7
07:10 am
anab
Medium
AnaptysBio Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/6
02:10 pm
anab
Low
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at HC Wainwright from $55.00 to $52.00. They now have a "buy" rating on the stock.
11/5/2024
04:15 pm
ANAB
11.7%
BEAT
8/5/2024
04:15 pm
ANAB
-0.9%
MISS
5/9/2024
04:15 pm
ANAB
-12.9%
MISS
3/11/2024
04:15 pm
ANAB
11.6%
BEAT
11/14
06:29 pm
Reiterates
Outperform
Wedbush
Medium
-8.2%
11/14
06:29 pm
Reiterates
Outperform
Wedbush
Medium
-8.2%
11/12
10:41 am
Maintains
Overweight
Overweight
JP Morgan
Low
-2.1%
11/6
10:28 am
Reiterates
Outperform
Wedbush
Low
-2.4%
11/6
10:28 am
Reiterates
Outperform
Wedbush
Low
-2.4%
11/18
07:30 am
anab
Medium
Form EFFECT ANAPTYSBIO, INC
11/15
04:06 pm
anab
Low
Form 424B5 ANAPTYSBIO, INC
11/14
04:00 pm
anab
Medium
Form SC 13G/A ANAPTYSBIO, INC Filed by: TANG CAPITAL MANAGEMENT LLC
11/14
09:25 am
anab
Low
Form SC 13G/A ANAPTYSBIO, INC Filed by: Deep Track Capital, LP
11/5
04:28 pm
anab
Medium
Form S-3 ANAPTYSBIO, INC
Show more
Top News Gainers
3/2 Form 10-K ANAPTYSBIO, INC For: Dec 31 18.7%
6/21 AnaptysBio Inc (NASDAQ: ANAB) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. 11.8%
12/10 Form SC 13G/A ANAPTYSBIO, INC Filed by: FMR LLC 8.2%
10/1 Investors Yawn As Biotech Puts Up Positive Test Results — For 2 Patients [Investor's Business Daily] 8.1%
11/22 Form SC 13G ANAPTYSBIO, INC Filed by: TANG CAPITAL PARTNERS LP 7.8%
3/3 AnaptysBio Inc (NASDAQ: ANAB) had its price target lowered by analysts at SunTrust Banks, Inc. from $15.00 to $14.00. They now have a "hold" rating on the stock. 6.3%
5/1 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB 5.4%
4/17 Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against of AnaptysBio, Inc. (ANAB) 5.2%
4/8 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RTI Surgical, AnaptysBio, Hanmi Financial, and HF Foods Group and Encourages Investors to Contact the Firm 5.2%
4/13 CLASS ACTION UPDATE for ANAB, VMW and ZM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders 5.0%
Top News Decliners
8/19 Form 8-K ANAPTYSBIO, INC For: Aug 16 -13.6%
9/30 Form 8-K ANAPTYSBIO, INC For: Sep 30 -11.8%
6/24 AnaptysBio Inc (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at SunTrust Banks, Inc.. -11.4%
6/21 AnaptysBio Inc (NASDAQ: ANAB) was downgraded by analysts at Credit Suisse Group AG from an "outperform" rating to a "neutral" rating. -8.9%
8/10 AnaptysBio Prepares for a Potential Gear Shift [The Motley Fool] -7.8%
3/10 Form 4 ANAPTYSBIO, INC For: Mar 10 Filed by: Suria Hamza -7.2%
2/12 Form SC 13G/A ANAPTYSBIO, INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C. -7.0%
9/25 Form 8-K ANAPTYSBIO, INC For: Sep 24 -6.8%
3/31 ANAPTYSBIO SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AnaptysBio, Inc. - ANAB -5.9%
3/27 INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm -5.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3